Stockreport

PepGen Reports Fourth Quarter and Year-End 2024 Financial Results and Recent Corporate Highlights [Yahoo! Finance]

PepGen Inc.  (PEPG) 
PDF – FREEDOM-DM1 15 mg/kg cohort is dosing, with results expected in second half of 2025 – – CONNECT1-EDO51 10 mg/kg cohort is fully enrolled, with results expected in t [Read more]